CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome

Histopathology

Volumn 52, Issue 2, 2008, Pages 203-212

  La Rocca, G ^a,e   Anzalone, R ^a   Corrao, S ^a   Magno, F ^a   Rappa, F ^b   Marasa S ^b   Czarnecka, A M ^c   Marasa L ^b   Sergi, C ^d   Zummo, G ^a   Cappello, F ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Ospedale Civico M Ascoli   (Italy)

^c UNIVERSITY OF WARSAW   (Poland)

^d MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^e Sezione Anatomia Umana   (Italy)

Author keywords

Antitumour response; Breast cancer; CD1a; Dendritic cells; Ductal carcinoma

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; T6 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER IMMUNOLOGY; CANCER INVASION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; DOWN REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; ANTIGENS, CD1; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 37549071865     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02919.x     Document Type: Article

References (15)

1. Coventry B, Heinzel S. CD1a in human cancers: a new role for an old molecule. Trends Immunol. 2004 25 242 248.
2. Coventry BJ, Morton J. CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer. Br. J. Cancer 2003 89 533 538.
3. Poindexter NJ, Sahin A, Hunt KK, Grimm EA. Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer. Breast Cancer Res. 2004 6 R408 R415.
4. Treilleux I, Blay JY, Bendriss-Vermare N et al. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin. Cancer Res. 2004 10 7466 7474.
5. Cappello F, Rappa F, Bucchieri F, Zummo G. CD1a: a novel biomarker for Barrett's metaplasia? Lancet Oncol. 2003 4 497.
6. Cappello F, Rappa F, Anzalone R, La Rocca G, Zummo G. CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer. Br. J. Cancer 2005 92 888 890.
7. La Rocca G, Anzalone R, Bucchieri F, Farina F, Cappello F, Zummo G. CD1a and antitumour immune response. Immunol. Lett. 2004 95 1 4.
8. De Libero G. The Robin Hood of antigen presentation. Science 2004 303 485 487.
9. Hillenbrand EE, Neville AM, Coventry BJ. Immunoistochemical localization of Cd1a-positive putative dendritic cells in human breast tumours. Br. J. Cancer, 1999 79 940 944.
10. Laguens G, Coronato S, Laguens R, Portiansky E, Di Girolamo V. Human regional lymph nodes draining cancer exhibit a profound dendritic cell depletion as comparing to those from patients without malignancies. Immunol. Lett. 2002 84 159 162.
11. Bell D, Chomarat P, Broyles D et al. In breast carcinoma tissue, immature dendritic cells reside within the tumour, whereas mature dendritic cells are located in peritumoral areas. J. Exp. Med. 1999 190 1417 1425.
12. Kikuchi K, Kusama K, Taguchi K et al. Dendritic cells in human squamous cell carcinoma of the oral cavity. Anticancer Res. 2002 22 545 557.
13. Kohrt HE, Nouri N, Nowels K, Johnson D, Holmes S, Lee PP. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med. 2005 2 e248.
14. Kichler-Lakomy C, Budinsky AC, Wolfram R et al. Deficiencies in phenotype expression and function of dendritic cells in patients with early breast cancer. Eur. J. Med. Res. 2006 11 7 12.
15. Pinzon-Charry A, Maxwell T, McGuckin MA, Schmidt C, Furnival C, Lopez JA. Spontaneous apoptosis of blood dendritic cells in patients with breast cancer. Breast Cancer Res. 2006 8 R5.